| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Internet and Businesses Online > Spam Blocker > How Do I Get Them to Stop Forwarding Me E-mails?! |
|
Main Subject - How Do I Get Them to Stop Forwarding Me E-mails?!
I get several requests each day from mothers, daughters, fathers and sons, friends and associates about how to nicely According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ask someone they know, like or love to please stop forwarding e-mail to them. Unfortunately, there is no nice way. No ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in matter how nice, how kind, how thoughtful you may be in asking someone to stop forwarding e-mails, they will either ha lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ve hurt feelings or get downright belligerent in the belief that they can do what they want. See, the problem isn't r here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ally the forwards. It is how they are forwarded. Although the forwarders are thinking they are being thoughtful, they d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro are in fact being proportionality the opposite because they do not forward properly. All one has to do is stop and t ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc hink of the person on the other side -- not just what they want to do or what will make them feel important at that mo easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ent in time. The two critical issues here are:
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically t everyone will not be interested in the topic of that e-mail. So you need to take the time to choose who you and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ forward to because you know they will be interested. ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ail is being forwarded to. Now, that certainly isn't very "thoughtful!" If you cannot type a brief comment to the spec ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ific person you are forwarding to about why you are forwarding them that specific e-mail, then don't forward at all. dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod li> To all the thoughtless uncontrollable forwarders out there, if you get asked by someone to not forward futur cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin e e-mails, kindly respect their request. Don't get hurt feelings and certainly don't act like you have a right to disr tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen gard someone's legitimate desire to not get e-mails they have no interest in receiving. And know that those who make t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel these requests still want to hear from you -- they just don't have the time or their e-mail volume is such that extran ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust eous forwards about silly, political or humorous topics that they are not interested in are what they no longer want t y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products receive. If you are sending unasked for forwards to everyone on your list, without comment, maybe you should be more . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de genuinely thoughtful by being selective about what you forward and to whom. A good rule of thumb is that if an e-mail elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip says "forward to everyone you know, all your friends or everyone in your address book" it is best you just hit Delete tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:India a Global Platform for Knowledge Outsourcing Gaining Link Popularity Techniques
|